Elongation of fatty acids protein, responsible for very long carbon chain llipid biosynthesis (conserved in Eukaryota).. This group of enzymes has expanded heavily in kinetoplastids.. Localization: ER (by homology)
Fatty acid metabolism, Elongation of fatty acids
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 53 |
NetGPI | no | yes: 0, no: 53 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 48 |
GO:0110165 | cellular anatomical entity | 1 | 50 |
GO:0005737 | cytoplasm | 2 | 2 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: E9AGL2
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 54 |
GO:0006629 | lipid metabolic process | 3 | 54 |
GO:0006631 | fatty acid metabolic process | 4 | 54 |
GO:0006633 | fatty acid biosynthetic process | 5 | 54 |
GO:0008152 | metabolic process | 1 | 54 |
GO:0008610 | lipid biosynthetic process | 4 | 54 |
GO:0009058 | biosynthetic process | 2 | 54 |
GO:0009987 | cellular process | 1 | 54 |
GO:0016053 | organic acid biosynthetic process | 4 | 54 |
GO:0019752 | carboxylic acid metabolic process | 5 | 54 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 54 |
GO:0043436 | oxoacid metabolic process | 4 | 54 |
GO:0044237 | cellular metabolic process | 2 | 54 |
GO:0044238 | primary metabolic process | 2 | 54 |
GO:0044249 | cellular biosynthetic process | 3 | 54 |
GO:0044255 | cellular lipid metabolic process | 3 | 54 |
GO:0044281 | small molecule metabolic process | 2 | 54 |
GO:0044283 | small molecule biosynthetic process | 3 | 54 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 54 |
GO:0071704 | organic substance metabolic process | 2 | 54 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 54 |
GO:1901576 | organic substance biosynthetic process | 3 | 54 |
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 6 |
GO:0006643 | membrane lipid metabolic process | 4 | 6 |
GO:0006665 | sphingolipid metabolic process | 4 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 7 | 6 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 7 | 6 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 6 |
GO:0030497 | fatty acid elongation | 6 | 6 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 8 | 6 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 8 | 6 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 6 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 6 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 54 |
GO:0004312 | fatty acid synthase activity | 5 | 54 |
GO:0009922 | fatty acid elongase activity | 6 | 54 |
GO:0016740 | transferase activity | 2 | 54 |
GO:0016746 | acyltransferase activity | 3 | 54 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 54 |
GO:0102756 | very-long-chain 3-ketoacyl-CoA synthase activity | 5 | 54 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.228 |
CLV_NRD_NRD_1 | 237 | 239 | PF00675 | 0.325 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.284 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.344 |
CLV_PCSK_PC1ET2_1 | 146 | 148 | PF00082 | 0.284 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.469 |
DOC_CDC14_PxL_1 | 71 | 79 | PF14671 | 0.258 |
DOC_MAPK_MEF2A_6 | 204 | 212 | PF00069 | 0.388 |
DOC_PP1_RVXF_1 | 144 | 151 | PF00149 | 0.418 |
DOC_PP1_RVXF_1 | 245 | 251 | PF00149 | 0.339 |
DOC_PP2B_LxvP_1 | 36 | 39 | PF13499 | 0.225 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.347 |
LIG_Actin_WH2_2 | 256 | 272 | PF00022 | 0.392 |
LIG_BRCT_BRCA1_1 | 260 | 264 | PF00533 | 0.252 |
LIG_EH1_1 | 154 | 162 | PF00400 | 0.297 |
LIG_EH1_1 | 181 | 189 | PF00400 | 0.256 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.251 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.237 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.291 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.220 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.291 |
LIG_LIR_Apic_2 | 266 | 271 | PF02991 | 0.384 |
LIG_LIR_Apic_2 | 70 | 75 | PF02991 | 0.198 |
LIG_LIR_Gen_1 | 137 | 148 | PF02991 | 0.257 |
LIG_LIR_Gen_1 | 211 | 220 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 255 | 265 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.262 |
LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 196 | 202 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 211 | 215 | PF02991 | 0.281 |
LIG_LIR_Nem_3 | 255 | 260 | PF02991 | 0.254 |
LIG_LIR_Nem_3 | 70 | 74 | PF02991 | 0.282 |
LIG_Pex14_2 | 123 | 127 | PF04695 | 0.353 |
LIG_Pex14_2 | 150 | 154 | PF04695 | 0.301 |
LIG_Pex14_2 | 260 | 264 | PF04695 | 0.257 |
LIG_Pex14_2 | 82 | 86 | PF04695 | 0.286 |
LIG_PTAP_UEV_1 | 204 | 209 | PF05743 | 0.304 |
LIG_SH2_CRK | 116 | 120 | PF00017 | 0.235 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.262 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.214 |
LIG_SH2_GRB2like | 109 | 112 | PF00017 | 0.218 |
LIG_SH2_GRB2like | 91 | 94 | PF00017 | 0.135 |
LIG_SH2_PTP2 | 202 | 205 | PF00017 | 0.479 |
LIG_SH2_STAP1 | 167 | 171 | PF00017 | 0.243 |
LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.274 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.287 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.226 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.260 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.263 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.198 |
LIG_SH3_1 | 202 | 208 | PF00018 | 0.499 |
LIG_SH3_1 | 268 | 274 | PF00018 | 0.434 |
LIG_SH3_3 | 202 | 208 | PF00018 | 0.404 |
LIG_SH3_3 | 268 | 274 | PF00018 | 0.409 |
LIG_SUMO_SIM_par_1 | 60 | 66 | PF11976 | 0.258 |
LIG_TYR_ITIM | 254 | 259 | PF00017 | 0.297 |
LIG_UBA3_1 | 126 | 131 | PF00899 | 0.291 |
LIG_WRC_WIRS_1 | 209 | 214 | PF05994 | 0.343 |
LIG_WRC_WIRS_1 | 5 | 10 | PF05994 | 0.363 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.373 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.418 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.235 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.440 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.271 |
MOD_N-GLC_1 | 169 | 174 | PF02516 | 0.417 |
MOD_N-GLC_2 | 12 | 14 | PF02516 | 0.532 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.273 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.282 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.230 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.327 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.227 |
MOD_NEK2_1 | 252 | 257 | PF00069 | 0.270 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.253 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.307 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.276 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.212 |
MOD_NEK2_2 | 84 | 89 | PF00069 | 0.299 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.315 |
MOD_Plk_1 | 282 | 288 | PF00069 | 0.696 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.278 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.275 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.258 |
MOD_Plk_4 | 225 | 231 | PF00069 | 0.249 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.265 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.260 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.281 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.281 |
TRG_AP2beta_CARGO_1 | 137 | 147 | PF09066 | 0.132 |
TRG_DiLeu_BaEn_1 | 22 | 27 | PF01217 | 0.379 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.241 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.271 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.259 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.248 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.266 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.218 |
TRG_ER_diArg_1 | 147 | 150 | PF00400 | 0.302 |
TRG_ER_diLys_1 | 296 | 299 | PF00400 | 0.654 |
TRG_NLS_MonoExtC_3 | 144 | 149 | PF00514 | 0.493 |
TRG_NLS_MonoExtN_4 | 145 | 150 | PF00514 | 0.302 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0C5PHQ7 | Tachysurus fulvidraco | 24% | 100% |
A0A0N0P5E5 | Leptomonas seymouri | 42% | 100% |
A0A0N0P7D1 | Leptomonas seymouri | 61% | 90% |
A0A0N0P7D6 | Leptomonas seymouri | 33% | 100% |
A0A0N0P7R2 | Leptomonas seymouri | 71% | 98% |
A0A0N1HZJ8 | Leptomonas seymouri | 40% | 92% |
A0A0N1I9H5 | Leptomonas seymouri | 32% | 100% |
A0A0N1ILQ4 | Leptomonas seymouri | 39% | 100% |
A0A0N1IM10 | Leptomonas seymouri | 30% | 100% |
A0A0N1PDR8 | Leptomonas seymouri | 37% | 100% |
A0A0S4IS29 | Bodo saltans | 48% | 100% |
A0A0S4IVJ6 | Bodo saltans | 33% | 94% |
A0A0S4IVS6 | Bodo saltans | 42% | 100% |
A0A0S4IW98 | Bodo saltans | 45% | 94% |
A0A0S4KMP5 | Bodo saltans | 24% | 91% |
A0A1X0NNK7 | Trypanosomatidae | 39% | 100% |
A0A1X0NNL0 | Trypanosomatidae | 33% | 99% |
A0A1X0NNM4 | Trypanosomatidae | 35% | 100% |
A0A1X0NNM5 | Trypanosomatidae | 49% | 97% |
A0A1X0NP89 | Trypanosomatidae | 39% | 94% |
A0A3Q8I8T7 | Leishmania donovani | 32% | 76% |
A0A3Q8I9T2 | Leishmania donovani | 31% | 80% |
A0A3Q8I9U9 | Leishmania donovani | 40% | 92% |
A0A3Q8I9X8 | Leishmania donovani | 59% | 89% |
A0A3Q8IC05 | Leishmania donovani | 39% | 98% |
A0A3Q8ID51 | Leishmania donovani | 31% | 75% |
A0A3Q8IIA9 | Leishmania donovani | 34% | 100% |
A0A3R7KG78 | Trypanosoma rangeli | 43% | 100% |
A0A3R7MJR2 | Trypanosoma rangeli | 37% | 100% |
A0A3R7NSQ3 | Trypanosoma rangeli | 36% | 100% |
A0A3S5H6R7 | Leishmania donovani | 31% | 100% |
A0A3S5H6R8 | Leishmania donovani | 38% | 100% |
A0A3S7WSY8 | Leishmania donovani | 34% | 100% |
A0A3S7WSZ1 | Leishmania donovani | 99% | 100% |
A0A3S7WT03 | Leishmania donovani | 91% | 100% |
A0A3S7WT16 | Leishmania donovani | 45% | 93% |
A0A422NNP1 | Trypanosoma rangeli | 51% | 100% |
A0JNC4 | Bos taurus | 28% | 100% |
A1L3X0 | Homo sapiens | 28% | 100% |
A4H7M2 | Leishmania braziliensis | 32% | 96% |
A4H7M3 | Leishmania braziliensis | 32% | 100% |
A4H7M4 | Leishmania braziliensis | 33% | 95% |
A4H7M5 | Leishmania braziliensis | 35% | 96% |
A4H7M6 | Leishmania braziliensis | 77% | 100% |
A4H7M7 | Leishmania braziliensis | 43% | 100% |
A4H7M8 | Leishmania braziliensis | 28% | 100% |
A4H7M9 | Leishmania braziliensis | 30% | 100% |
A4H7N0 | Leishmania braziliensis | 39% | 98% |
A4HW07 | Leishmania infantum | 34% | 98% |
A4HW08 | Leishmania infantum | 31% | 99% |
A4HW09 | Leishmania infantum | 34% | 97% |
A4HW10 | Leishmania infantum | 35% | 98% |
A4HW12 | Leishmania infantum | 59% | 100% |
A4HW13 | Leishmania infantum | 40% | 100% |
A4HW14 | Leishmania infantum | 44% | 100% |
A4HW15 | Leishmania infantum | 31% | 100% |
A4HW16 | Leishmania infantum | 31% | 100% |
A4HW17 | Leishmania infantum | 32% | 100% |
A4HW18 | Leishmania infantum | 39% | 99% |
C9ZT13 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 99% |
C9ZT15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
C9ZT16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 98% |
D4A612 | Rattus norvegicus | 25% | 100% |
D4ADY9 | Rattus norvegicus | 29% | 100% |
E8NHR1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 100% |
E8NHR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E8NHR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AGL0 | Leishmania infantum | 90% | 100% |
E9APQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9APR0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9APR1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 97% |
E9APR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 100% |
E9APR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
E9APR4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
E9APR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% |
E9APR6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
E9APR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 44% | 100% |
E9APR8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9APR9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
G5EEE5 | Caenorhabditis elegans | 33% | 100% |
O35949 | Mus musculus | 31% | 100% |
P39540 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 24% | 96% |
P49191 | Caenorhabditis elegans | 32% | 93% |
Q03574 | Caenorhabditis elegans | 30% | 100% |
Q20300 | Caenorhabditis elegans | 30% | 100% |
Q20303 | Caenorhabditis elegans | 32% | 100% |
Q2KJD9 | Bos taurus | 23% | 100% |
Q32NI8 | Xenopus laevis | 25% | 100% |
Q3S8M4 | Macaca mulatta | 25% | 95% |
Q4QFQ9 | Leishmania major | 41% | 100% |
Q4QFR0 | Leishmania major | 33% | 100% |
Q4QFR1 | Leishmania major | 30% | 100% |
Q4QFR2 | Leishmania major | 31% | 100% |
Q4QFR3 | Leishmania major | 43% | 100% |
Q4QFR4 | Leishmania major | 40% | 100% |
Q4QFR5 | Leishmania major | 59% | 100% |
Q4QFR6 | Leishmania major | 89% | 100% |
Q4QFR7 | Leishmania major | 38% | 100% |
Q4QFR8 | Leishmania major | 33% | 95% |
Q4QFR9 | Leishmania major | 31% | 100% |
Q4QFS0 | Leishmania major | 34% | 100% |
Q4R516 | Macaca fascicularis | 23% | 100% |
Q5M8U1 | Xenopus tropicalis | 24% | 100% |
Q5RFL5 | Pongo abelii | 23% | 100% |
Q5ZJR8 | Gallus gallus | 32% | 100% |
Q6PC64 | Danio rerio | 35% | 100% |
Q7LKX0 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 82% |
Q8BHI7 | Mus musculus | 24% | 100% |
Q920L5 | Mus musculus | 31% | 100% |
Q920L6 | Rattus norvegicus | 31% | 100% |
Q920L7 | Rattus norvegicus | 23% | 100% |
Q95K73 | Macaca fascicularis | 25% | 95% |
Q9BW60 | Homo sapiens | 25% | 100% |
Q9D2Y9 | Mus musculus | 29% | 100% |
Q9EQC4 | Mus musculus | 24% | 96% |
Q9GZR5 | Homo sapiens | 23% | 95% |
Q9H5J4 | Homo sapiens | 33% | 100% |
Q9HB03 | Homo sapiens | 30% | 100% |
Q9JLJ5 | Mus musculus | 25% | 100% |
Q9NYP7 | Homo sapiens | 23% | 100% |
Q9UTF7 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 90% |
Q9VV87 | Drosophila melanogaster | 35% | 95% |
Q9XVQ9 | Caenorhabditis elegans | 28% | 100% |
V5BE99 | Trypanosoma cruzi | 40% | 100% |
V5BIX9 | Trypanosoma cruzi | 40% | 100% |
V5BND3 | Trypanosoma cruzi | 52% | 100% |
V5DF68 | Trypanosoma cruzi | 36% | 100% |